Weekly Healthcare Market Update: Focus on Eli Lilly, Merck, and AstraZeneca Amid Broad Market Decline
Major U.S. stock indices experienced significant losses this week as investors reacted to disappointing earnings reports within the technology sector. The S&P 500 fell by 1.82%, while the Nasdaq Composite saw a sharper decline of 2.86%, reflecting a broader sell-off in tech-heavy portfolios. Despite the general market downturn, attention remains focused on key players in the healthcare sector, specifically Eli Lilly, Merck, and AstraZeneca. These companies are being closely monitored by analysts as investors look for stability or specific catalysts within the pharmaceutical industry to offset losses seen in other sectors.